Amedisys, Inc. (AMED) Posts Q3 EPS of 6c; Trims FY13 Outlook
Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.06, $0.07 worse than the analyst estimate of $0.13. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)